Form 4 holding
Director
Allogene Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 2,236,816
- Estimated value
- $3,064,437
- Report date
- 02 Feb 2026
- Price
- $1.37
- Ownership
- Direct
Arie Belldegrun - Director at Allogene Therapeutics, Inc.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- Director
- Issuer Symbol
- ALLO on Nasdaq
- All Insider Reports
- All Insider Reports
There are no Buy or Sell transactions made by Arie Belldegrun since 23 May 2025
Holdings reported by Arie Belldegrun for Allogene Therapeutics, Inc.
Form 4 holding
Director
Allogene Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 539,867
- Estimated value
- $739,617
- Report date
- 02 Feb 2026
- Price
- $1.37
- Ownership
- Indirect
Form 4 holding
Director
Allogene Therapeutics, Inc.
- Security class
- Stock Option (Right to buy)
- Shares / value
- 929,913
- Estimated value
- Report date
- 02 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Allogene Therapeutics, Inc.
- Security class
- Restricted Stock Unit
- Shares / value
- 263,033
- Estimated value
- Report date
- 02 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by Arie Belldegrun for Allogene Therapeutics, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.